EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ferroptosis in Cancer: Mechanism and Therapeutic Potential

Mansaa Singh, Hasmiq L Arora iD, Rutuja Naik iD, Shravani Joshi, Kaveri Sonawane iD, Nilesh Kumar Sharma iD, Birandra K Sinha

International Journal of Molecular Sciences · 18.04.2025 · 26 (8) · 3852

DOI: 10.3390/ijms26083852 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.04.2025. Verfasst von Mansaa Singh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer and Translational Research Lab, Dr. D.Y. Patil Biotechnology & Bioinformatics Institute, Dr. D.Y. Patil Vidyapeeth, Pune 411033, India. Hauptthemen laut MEDLINE: Ferroptosis, Neoplasms. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: intramural research program of the National Institute of Environmental Health Sciences, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer drug resistance occurs when cancer cells evade cell death following treatment with chemotherapy, radiation therapy, and targeted therapies. This resistance is often linked to the reprogramming of programmed cell death (PCD) pathways, allowing cancer cells to survive drug-induced stress. However, certain anticancer therapies, when combined with specific agents or inhibitors, can induce ferroptosis—a form of cell death driven by iron-dependent lipid peroxidation. Currently, extensive preclinical and clinical research is underway to investigate the molecular, cellular, and tissue-specific mechanisms underlying ferroptosis, with the goal of identifying strategies to overcome drug resistance in cancers unresponsive to conventional PCD pathways. By harnessing ferroptosis, cancer cells can be compelled to undergo lipid peroxidation-induced death, potentially improving therapeutic outcomes in patients with cancer. This short review aims to enhance the understanding of ferroptosis inducers in cancer therapy and stimulate further research into ferroptosis-based approaches for more effective clinical cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisNeoplasmsHumansLipid PeroxidationAnimalsAntineoplastic AgentsIronDrug Resistance, Neoplasm

Stichwörter der Autor:innen

cell deathferroptosisironlipid peroxidationoxidative stresssignaling

Substanzen

Antineoplastic AgentsIron

Autor:innen und Institutionen

  • Cancer and Translational Research Lab, Dr. D.Y. Patil Biotechnology & Bioinformatics Institute, Dr. D.Y. Patil Vidyapeeth, Pune 411033, India.
  • Mechanistic Toxicology Branch, Division of Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, Durham, NC 27709, USA.

ORCID-Profile: Hasmiq L Arora, Rutuja Naik, Kaveri Sonawane, Nilesh Kumar Sharma

Förderung

  • intramural research program of the National Institute of Environmental Health Sciences, NIH

Zitieren

APA

Singh, M., Arora, H. L., Naik, R., Joshi, S., Sonawane, K., Sharma, N. K., & Sinha, B. K. (2025). Ferroptosis in Cancer: Mechanism and Therapeutic Potential. International Journal of Molecular Sciences, 26(8), 3852. https://doi.org/10.3390/ijms26083852

Vancouver

Singh M, Arora HL, Naik R, Joshi S, Sonawane K, Sharma NK, et al. Ferroptosis in Cancer: Mechanism and Therapeutic Potential. International Journal of Molecular Sciences. 2025;26(8):3852. doi:10.3390/ijms26083852

BibTeX
@article{Singh2025,
  author = {Singh, Mansaa and Arora, Hasmiq L and Naik, Rutuja and Joshi, Shravani and Sonawane, Kaveri and Sharma, Nilesh Kumar and Sinha, Birandra K},
  title = {Ferroptosis in Cancer: Mechanism and Therapeutic Potential},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {8},
  pages = {3852},
  doi = {10.3390/ijms26083852}
}
Kostenlos starten →